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ABSTRACT
BACKGROUND: Haemorrhoids are variceal dilatations of the anal and 
perianal venous plexus and often develop secondary to the persistently el-
evated venous pressure within the haemorrhoidal plexus. Phlebotonics are 
a heterogenous class of drugs consisting of plant extracts (i.e. flavonoids) 
and synthetic compounds (i.e. calcium dobesilate). Although their precise 
mechanism of action has not been fully established, they are known to im-
prove venous tone, stabilize capillary permeability and increase lymphatic 
drainage. They have been used to treat a variety of conditions including 
chronic venous insufficiency, lymphoedema and haemorrhoids.
OBJECTIVE: The aim of this review was to investigate the efficacy of 
phlebotonics in alleviating the signs, symptoms and severity of haem-
orrhoidal disease and verify their effect post-haemorrhoidectomy.
METHODS:
Search methods: We searched the Cochrane Central Register of Con-
trolled Trials (CENTRAL) in the Cochrane Library 2011 issue 9, MEDLINE 
(1950 to September 2011) and EMBASE (1974 to September 2011).
Selection criteria: Only randomized controlled trials evaluating the use 
of phlebotonics in treating haemorrhoidal disease were used. No cross-
over or cluster-randomized trials were included for analysis and any trial 
which had a quasi-random method of allocation was excluded.
Data collection and analysis: Two authors independently extracted the 
data and analyzed the eligibility of the data for inclusion. Disagree-
ments were resolved by meaningful discussion.
MAIN RESULTS: We considered twenty-four studies for inclusion in the 
final analysis. Twenty of these studies (enrolling a total of 2344 partici-
pants) evaluated the use of phlebotonics versus a control intervention. 
One of these twenty studies evaluated the use of phlebotonics with 
a medical intervention and another study with rubber band ligation.
AUTHORS’ CONCLUSIONS: The evidence suggests that there is a po-
tential benefit in using phlebotonics in treating haemorrhoidal disease 
as well as a benefit in alleviating post-haemorrhoidectomy symptoms. 
Outcomes such as bleeding and overall symptom improvement show 
a statistically significant beneficial effect and there were few concerns 
regarding their overall safety from the evidence presented in the clinical 
trials.Only randomized controlled trials evaluating the use of phlebo-
tonics in treating haemorrhoidal disease were used. No cross-over or 
cluster-randomized trials were included for analysis and any trial which 
had a quasi-random method of allocation was excluded.
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COMMENTS
Hemorrhoidal disease is responsible for frequent seeking of medical at-
tention, due to a variable range of symptoms and signs. It is often treat-
ed through use of supplementary fiber in the diet and local medication. 
Use of phlebotonics for treating hemorrhoids has always been a matter 
of discussion because the evidence in the literature has not indicated 
that they should be used routinely. Their action seems to be based on 
increasing the strength and tone of the vessel wall, thereby improving 
lymphatic drainage and normalizing capillary permeability. 
The aim of this systematic review was to observe the action of these 
substances in relieving the symptoms of hemorrhoids and their effect 
during the postoperative period following hemorrhoidectomy. Twenty-
four prospective randomized studies that evaluated the use of phlebo-
tonics in hemorrhoidal disease were selected using strict criteria. These 
studies compared use of phlebotonics with control interventions or 
even elastic ligation. 
The results, based on statistically significant numbers, showed that 
these substances are safe to use, with a low rate of side effects, and that 
they provide improvements in symptoms with regard to bleeding and 
postoperative pain, and in other symptoms such as itching.  
Thus, this systematic review has obtained the evidence that is needed for 
phlebotonics to be used in medical treatments for hemorrhoidal disease. 
Sarhan Sydney Saad. MD, PhD. Associate Full Professor and Head of 
the Coloproctology Group, Discipline of Gastrointestinal Surgery, Es-
cola Paulista de Medicina – Universidade Federal de São Paulo (EPM-
Unifesp), São Paulo (SP), Brazil.
